Key facts
- FOLX Health’s last known valuation is $124.7M (Oct 2022).
- It has raised $59.0M across 3 recorded rounds; the latest was Early Stage VC ($30.0M) in Oct 2022.
- Notable investors include Bessemer Venture Partners, Polaris Partners, Foresite Capital, Define Ventures, Seae Ventures — 6 tracked in total.
- FOLX Health has filed 4 Form Ds with the SEC since 2020, most recently Oct 2022 ($30.0M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for FOLX Health
Funding rounds
3 roundsAbout FOLX Health
Operator of a digital health company intended to serve the queer and trans communities. The company offers unlimited, virtual access to clinicians, discreet delivery of at-home kits for medications, labs and supplies, hormone replacement therapy, HIV prevention, fertility testing and general medical services specifically tailored to the queer community, enabling LGBTQ users to take care of themselves, avoiding barriers and stigma of society.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2020
- Employees
- 66
- Website
- folxhealth.com/
- Ownership
- Privately Held (backing)
FOLX Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FOLX Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FOLX Health in its N-PORT filings yet. We sweep new filings monthly.